These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 24446072)

  • 1. Bayesian modeling of cost-effectiveness studies with unmeasured confounding: a simulation study.
    Stamey JD; Beavers DP; Faries D; Price KL; Seaman JW
    Pharm Stat; 2014; 13(1):94-100. PubMed ID: 24446072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the impact of unmeasured confounding with internal validation data: an example cost evaluation in type 2 diabetes.
    Faries D; Peng X; Pawaskar M; Price K; Stamey JD; Seaman JW
    Value Health; 2013; 16(2):259-66. PubMed ID: 23538177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sign of the unmeasured confounding bias under various standard populations.
    Chiba Y
    Biom J; 2009 Aug; 51(4):670-6. PubMed ID: 19650054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian sensitivity analysis for unmeasured confounding in observational studies.
    McCandless LC; Gustafson P; Levy A
    Stat Med; 2007 May; 26(11):2331-47. PubMed ID: 16998821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "A Bayesian sensitivity analysis to evaluate the impact of unmeasured confounding with external data: a real world comparative effectiveness study in osteoporosis".
    Zhang X; Faries DE; Boytsov N; Stamey JD; Seaman JW
    Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):982-92. PubMed ID: 27396534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hierarchical priors for bias parameters in Bayesian sensitivity analysis for unmeasured confounding.
    McCandless LC; Gustafson P; Levy AR; Richardson S
    Stat Med; 2012 Feb; 31(4):383-96. PubMed ID: 22253142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sensitivity analysis using information about measured confounders yielded improved uncertainty assessments for unmeasured confounding.
    McCandless LC; Gustafson P; Levy AR
    J Clin Epidemiol; 2008 Mar; 61(3):247-55. PubMed ID: 18226747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjustment for unmeasured confounding through informative priors for the confounder-outcome relation.
    Groenwold RHH; Shofty I; Miočević M; van Smeden M; Klugkist I
    BMC Med Res Methodol; 2018 Dec; 18(1):174. PubMed ID: 30577773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. unmconf : an R package for Bayesian regression with unmeasured confounders.
    Hebdon R; Stamey J; Kahle D; Zhang X
    BMC Med Res Methodol; 2024 Sep; 24(1):195. PubMed ID: 39244581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On a preference-based instrumental variable approach in reducing unmeasured confounding-by-indication.
    Li Y; Lee Y; Wolfe RA; Morgenstern H; Zhang J; Port FK; Robinson BM
    Stat Med; 2015 Mar; 34(7):1150-68. PubMed ID: 25546152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twice-weighted multiple interval estimation of a marginal structural model to analyze cost-effectiveness.
    Goldfeld KS
    Stat Med; 2014 Mar; 33(7):1222-41. PubMed ID: 24151161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of Bayesian and Monte Carlo sensitivity analysis for unmeasured confounding.
    McCandless LC; Gustafson P
    Stat Med; 2017 Aug; 36(18):2887-2901. PubMed ID: 28386994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bias Formulas for Estimating Direct and Indirect Effects When Unmeasured Confounding Is Present.
    le Cessie S
    Epidemiology; 2016 Jan; 27(1):125-32. PubMed ID: 26426943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-stage instrumental variable methods for estimating the causal odds ratio: analysis of bias.
    Cai B; Small DS; Have TR
    Stat Med; 2011 Jul; 30(15):1809-24. PubMed ID: 21495062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity analyses for unmeasured confounding assuming a marginal structural model for repeated measures.
    Brumback BA; Hernán MA; Haneuse SJ; Robins JM
    Stat Med; 2004 Mar; 23(5):749-67. PubMed ID: 14981673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of observational studies with unmeasured confounders.
    McCandless LC
    Int J Biostat; 2012 Jan; 8(2):. PubMed ID: 22499731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The missing cause approach to unmeasured confounding in pharmacoepidemiology.
    Abrahamowicz M; Bjerre LM; Beauchamp ME; LeLorier J; Burne R
    Stat Med; 2016 Mar; 35(7):1001-16. PubMed ID: 26932124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlling for confounding in the presence of measurement error in hierarchical models: a Bayesian approach.
    Gryparis A; Coull BA; Schwartz J
    J Expo Sci Environ Epidemiol; 2007 Dec; 17 Suppl 2():S20-8. PubMed ID: 18079761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fixed effects analysis of repeated measures data.
    Gunasekara FI; Richardson K; Carter K; Blakely T
    Int J Epidemiol; 2014 Feb; 43(1):264-9. PubMed ID: 24366487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interpreting treatment-effect estimates with heterogeneity and choice: simulation model results.
    Brooks JM; Fang G
    Clin Ther; 2009 Apr; 31(4):902-19. PubMed ID: 19446162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.